top of page

Vitamin A - Part of the Superfood - Cod Liver Oil

Thanks to Wayne - a scientist and business person with many apparent talents - for following up with the following note after our presentation on Cod Liver Oil.


Vitamin A may treat anosmia (loss of smell) due to COVID-19

Once again, evidence emerges that widely available, dirt-cheap interventions may be able to treat a condition for which mainstream medicine claims there is no available cure. Namely, one of the most persistent and “baffling” symptoms associated with current or past COVID-19 experience is anosmia – the partial or full loss of smell.


Anosmia is actually a very common symptom of any viral infection, but the general public only became aware of this issue during the COVID-19 pandemic. It has been known since the 1960s that elevated serotonin is involved in the loss of smell and that anti-serotonin agents are therapeutic. It is now known that serotonin is heavily involved in the pathology of COVID-19 (and likely all other viral infections), yet doctors are afraid to discuss serotonin’s role or offer anti-serotonin therapies in fear of “killing the hen that lays golden eggs” – i.e. the multi-billion dollar SSRI drug industry.


Well, the studies below demonstrate that the loss of smell may be reversible by a simple regimen of putting 10,000 IU vitamin A daily in the nose, for 8 weeks. Considering most vitamin A products on the market are in the form of esters such as acetate or palmitate, the palmitate ester may be the way to go due to the acetate being potentially irritating to the nasal mucosa. If the vitamin A has been dissolved in tocopherols, the effect may be even stronger since anosmia is now known to involve lipid peroxidation and vitamin E can help with that, while also protecting vitamin A from peroxidation as the latter is just as vulnerable to this process as PUFA.

 

https://pubmed.ncbi.nlm.nih.gov/28434127/

https://fundingawards.nihr.ac.uk/award/NIHR201978

https://www.forbes.com/sites/roberthart/2021/09/29/vitamin-a-is-being-studied-in-the-uk-as-a-potential-treatment-to-covid-smell-loss/?sh=32e803546d6e


“…Vitamin A nose drops will be given to volunteer patients as part of a 12-week trial by the University of East Anglia (UEA), with the results compared to a group receiving a placebo of inactive drops. Previous research from Germany has “shown the potential benefit” of vitamin A in treating smell loss, UEA said, and the trial is designed to “explore how this treatment works to help repair tissues in the nose damaged by viruses.”


“…Philpott said around 1 in 10 Covid-19 patients who lost their sense of smell had not fully recovered four weeks after infection and said a “key problem” for patients and doctors is “the lack of proven effective treatments.” Philpott said the German study found that people treated with vitamin A “improved twice as much” as those who didn’t receive the treatment.”


 

But note that some caution that Excess Vitamin D can suppress Vitamin A


I’ve heard “experts” speak about high dose Vitamin D tabs suppressing Vitamin A and see Chris Masterjohn mention Vitamin A helping to prevent Vitamin D toxicity (which raises the question; what if Vitamin D is on the low side??)


 

Vitamin D Experts Defend Cod Liver Oil

In November of 2008, Dr. John Cannell of the Vitamin D Council published a commentary in the journal Annals of Otology, Rhinology & Laryngology attacking cod liver oil because of its high vitamin A content, claiming that vitamin A intakes above the most minimal levels would increase mortality rates, increase vulnerability to infections, cause osteoporosis, and antagonize the beneficial effects of vitamin D. Sixteen scientists signed on to the paper as co-authors. In response, Wise Traditions published my article, “The Cod Liver Oil Debate,” in the Spring, 2009 issue, which defended cod liver oil as an important and balanced source of the fat-soluble vitamins and essential fatty acids. The following November, I expanded on this article in my lecture, “Cod Liver Oil: Our Number One Superfood,” at the Foundation’s annual conference.

We’re not the only ones who responded!